Syntax Advisors, LLC Bristol Myers Squibb CO Transaction History
Syntax Advisors, LLC
- $57.7 Million
- Q3 2023
A detailed history of Syntax Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Syntax Advisors, LLC holds 3,808 shares of BMY stock, worth $204,718. This represents 0.38% of its overall portfolio holdings.
Number of Shares
3,808
Previous 3,550
7.27%
Holding current value
$204,718
Previous $227,000
2.64%
% of portfolio
0.38%
Previous 0.35%
Shares
8 transactions
Others Institutions Holding BMY
# of Institutions
2,403Shares Held
1.5BCall Options Held
29.7MPut Options Held
32.2M-
Vanguard Group Inc Valley Forge, PA187MShares$10 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.53 Billion0.15% of portfolio
-
State Street Corp Boston, MA91.4MShares$4.92 Billion0.17% of portfolio
-
Jpmorgan Chase & CO New York, NY74.6MShares$4.01 Billion0.27% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA59.1MShares$3.18 Billion0.47% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $114B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...